Polyglucosan body structure in Lafora disease

被引:19
|
作者
Brewer, M. Kathryn [1 ,2 ,3 ,4 ]
Putaux, Jean-Luc [5 ]
Rondon, Alberto [1 ]
Uittenbogaard, Annette [1 ]
Sullivan, Mitchell A. [6 ]
Gentry, Matthew S. [1 ,2 ,3 ]
机构
[1] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA
[2] Univ Kentucky, Coll Med, Lafora Epilepsy Cure Initiat Epilepsy & Brain Met, Lexington, KY 40536 USA
[3] Univ Kentucky, Coll Med, Ctr Struct Biol, Lexington, KY 40536 USA
[4] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain
[5] Univ Grenoble Alpes, CNRS, CERMAV, F-38000 Grenoble, France
[6] Univ Queensland, Mater Res Inst, Glycat & Diabet Grp, Translat Res Inst, Woolloongabba, Qld, Australia
基金
美国国家卫生研究院; 欧盟地平线“2020”;
关键词
glycogen; starch; epilepsy; polyglucosan bodies; Lafora bodies; Lafora disease; glycogen storage disease; E3 UBIQUITIN LIGASE; CHAIN-LENGTH; MYOCLONUS EPILEPSY; BRANCHING ENZYME; GLYCOGEN PHOSPHATE; CORPORA-AMYLACEA; STARCH GRANULES; BRAIN GLYCOGEN; MOUSE MODELS; WILD-TYPE;
D O I
10.1016/j.carbpol.2020.116260
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Abnormal carbohydrate structures known as polyglucosan bodies (PGBs) are associated with neurological disorders, glycogen storage diseases (GSDs), and aging. A hallmark of the GSD Lafora disease (LD), a fatal childhood epilepsy caused by recessive mutations in the EPM2A or EPM2B genes, are cytoplasmic PGBs known as Lafora bodies (LBs). LBs result from aberrant glycogen metabolism and drive disease progression. They are abundant in brain, muscle and heart of LD patients and Epm2a(-/-) and Epm2b(-/-) mice. LBs and PGBs are histologically reminiscent of starch, semicrystalline carbohydrates synthesized for glucose storage in plants. In this study, we define LB architecture, tissue-specific differences, and dynamics. We propose a model for how small poly-glucosans aggregate to form LBs. LBs are very similar to PGBs of aging and other neurological disorders, and so these studies have direct relevance to the general understanding of PGB structure and formation.
引用
下载
收藏
页数:14
相关论文
共 50 条
  • [1] PHOSPHORYLATION PREVENTS POLYGLUCOSAN TRANSPORT IN LAFORA DISEASE
    Girard, Jean-Marie
    Stone, Scellig S. D.
    Lohi, Hannes
    Blaszykowski, Christophe
    Teixeira, Catia
    Turnbull, Julie
    Wang, Afra
    Draginov, Arman
    Wang, Peixiang
    Zhao, Xiao Chu
    Ackerley, Cameron A.
    Frankland, Paul W.
    Minassian, Berge A.
    NEUROLOGY, 2012, 79 (01) : 100 - 102
  • [2] Polyglucosan storage disease in a dog resembling Lafora's disease
    Schoeman, T
    Williams, J
    van Wilpe, E
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2002, 16 (02) : 201 - 207
  • [3] LAFORA DISEASE - POLYGLUCOSAN STORAGE IN SKELETAL-MUSCLE
    LEWISCOL.D
    DIMAURO, S
    GAMBETTI, P
    NEUROLOGY, 1973, 23 (04) : 439 - &
  • [4] Progressive myoclonus epilepsy with polyglucosan bodies: Lafora disease
    Minassian, BA
    MYOCLONUS AND PAROXYSMAL DYSKINESIAS, 2002, 89 : 199 - 210
  • [5] POLYGLUCOSAN MYOPATHY - A LAFORA BODY-LIKE NEUROMUSCULAR DISORDER
    GOEBEL, HH
    GULLOTTA, F
    YOKOTA, T
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1988, 47 (03): : 311 - 311
  • [6] The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies
    Ganesh, S
    Tsurutani, N
    Suzuki, T
    Hoshii, Y
    Ishihara, T
    Delgado-Escueta, AV
    Yamakawa, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 313 (04) : 1101 - 1109
  • [7] Laforin Prevents Stress-Induced Polyglucosan Body Formation and Lafora Disease Progression in Neurons
    Wang, Yin
    Ma, Keli
    Wang, Peixiang
    Baba, Otto
    Zhang, Helen
    Parent, Jack M.
    Zheng, Pan
    Liu, Yang
    Minassian, Berge A.
    Liu, Yan
    MOLECULAR NEUROBIOLOGY, 2013, 48 (01) : 49 - 61
  • [8] Laforin Prevents Stress-Induced Polyglucosan Body Formation and Lafora Disease Progression in Neurons
    Yin Wang
    Keli Ma
    Peixiang Wang
    Otto Baba
    Helen Zhang
    Jack M. Parent
    Pan Zheng
    Yang Liu
    Berge A. Minassian
    Yan Liu
    Molecular Neurobiology, 2013, 48 : 49 - 61
  • [9] AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models
    Emrah Gumusgoz
    Sahba Kasiri
    Dikran R. Guisso
    Jun Wu
    Matthew Dear
    Brandy Verhalen
    Berge A. Minassian
    Neurotherapeutics, 2022, 19 : 982 - 993
  • [10] POLYGLUCOSAN BODY DISEASE
    ONAR, M
    MUSCLE & NERVE, 1992, 15 (04) : 519 - 519